Month: February 2025

SHIRLEY, N.Y., Feb. 11, 2025 (GLOBE NEWSWIRE) — Evome Medical Technologies Inc. (the “Company”) (TSXV: EVMT) issued a press release on Monday, February 10, 2025 announcing the details of an amendment (the “Amendment”) to the forbearance agreement dated August 4, 2023 between ‎the Company, Biodex Rehab Systems, LLC (“Biodex Rehab”), a wholly owned subsidiary of the Company, and ‎Biodex Medical Systems, Inc. (“Biodex Medical”), a wholly owned subsidiary of Biodex Rehab, and Mirion ‎Technologies (US), Inc. (“Mirion”). The Company clarifies that the reduction of debt as a result of the Amendment from $6.7 million due in July 2025 to $4.25 million due in April 2030 is subject to, and conditional on, the timely payment of monthly payments, beginning July 2024 and concluding in April 2030. In exchange, Biodex Medical has committed to...

VANCOUVER, British Columbia, Feb. 11, 2025 (GLOBE NEWSWIRE) — Zacatecas Silver Corp. (“Zacatecas Silver” or the “Company,” ZAC: TSX Venture; ZCTSF: OTC Markets; 7TV: Frankfurt) is pleased to announce that it has designed a drill program to follow up on previous work at its silver projects located in Zacatecas, Mexico. The Company will now seek bids from drill contractors based on the proposed program. The drilling plan aims to expand the current resource (see News Release dated May 30, 2023, for details) and follow up on previously drilled high-grade intercepts outside the known resource area. Drilling by the Company and previous operators has identified two significant vein systems warranting further exploration and drilling:Panuco Deposit: Extensive drilling and trench work at Panuco have returned high-grade silver results,...

Company’s European Business to Continue OAKLAND, Calif., Feb. 11, 2025 (GLOBE NEWSWIRE) — Getaround, Inc. (“Getaround” or the “Company”), a global car-sharing marketplace, announced today that it has plans to commence an orderly wind-down of its U.S. business operations, which includes its car-share and HyreCar businesses. Getaround’s European business will continue operating to provide car-sharing services for customers in all current European markets. “This has been an incredibly difficult decision, one that was not made lightly and only after careful consideration of various strategic options,” said AJ Lee, Interim CEO and COO. “Despite significant improvements in overall profitability and extensive restructuring efforts, the Company has faced an ongoing lack of liquidity which has made U.S. operations no longer...

GOMEKLI™ (mirdametinib) capsules and tablets for oral suspensionGOMEKLI™ (mirdametinib) capsules and tablets for oral suspensionSaqib Islam, SpringWorks Therapeutics CEOSaqib Islam, SpringWorks Therapeutics CEOSpringWorks Therapeutics, IncSpringWorks Therapeutics, Inc.GOMEKLI™ (mirdametinib) logoGOMEKLI™ (mirdametinib) logo– GOMEKLI is the first and only medicine approved for both adults and children with NF1-PN – – Approval based on positive data from Phase 2b ReNeu trial, which showed GOMEKLI treatment resulted in robust ORR, deep and durable reductions in tumor volume, and a manageable safety profile – – SpringWorks granted rare pediatric disease priority review voucher by the FDA – Photos accompanying this announcement are available at:  https://www.globenewswire.com/NewsRoom/AttachmentNg/8eb8effc-49a5-4b24-911f-d3e6dfa9c8a9https://www.globenewswire.com/NewsRoom/AttachmentNg/f1041678-3f79-43b7-a101-2390fb8cb86bhttps://www.globenewswire.com/NewsRoom/AttachmentNg/7d8cb318-e5f8-4944-8736-24cb19a5dec9https://www.globenewswire.com/NewsRoom/AttachmentNg/072d748b-3237-48ad-8d83-1c6c23dda65f STAMFORD,...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, Feb. 11, 2025 (GLOBE NEWSWIRE) — Prairie Provident Resources Inc. (TSX:PPR) (“Prairie Provident” or the “Company”) is pleased to announce that it has entered into an agreement with Research Capital Corporation, as lead agent and sole bookrunner, on behalf of a syndicate of agents including Haywood Securities Inc. (collectively, the “Agents”), for a brokered “best efforts” equity financing for aggregate gross proceeds of up to approximately $9,100,000, comprised of: (a) an offering up to 96,470,589 units of the Company (“Units”) at a price of $0.0425 per Unit for gross proceeds of up to $4,100,000, on a prospectus-exempt basis pursuant to the ‘listed issuer financing exemption’ (LIFE) under applicable Canadian securities laws...

Enforcement of Intellectual Property Remains Priority for Advancement of US Solar Industry PORTLAND, Tenn., Feb. 11, 2025 (GLOBE NEWSWIRE) — Shoals Technologies Group, Inc. (Shoals) (Nasdaq: SHLS), a global leader in electrical balance of system (EBOS) solutions for the energy transition market, announced today that it has filed a Petition for Review and Notice of Appeal to the United States Court of Appeals for the Federal Circuit. The appeal seeks review of the International Trade Commission (ITC) decision to reverse the Administrative Law Judge’s (ALJ) prior determination that Voltage’s LYNX trunk bus products infringe Shoals’ ’153 Patent. In the filing, Shoals requests that the Federal Circuit Court of Appeals review and overturn the ITC’s interpretation of the Shoals ’153 Patent. The review would be on a “de novo” basis, meaning...

Tel Aviv, Israel, Feb. 11, 2025 (GLOBE NEWSWIRE) — ParaZero Technologies Ltd. (Nasdaq: PRZO) (the “Company or “ParaZero”), an aerospace company focused on safety systems for commercial unmanned aircrafts and defense Counter UAS systems, today announces preliminary unaudited results for the year ended December 31, 2024. The Company’s revenues for the year ended December 31, 2024 are expected to increase by approximately 45% and are expected to amount to approximately $900,000, compared to revenues of approximately $620,000 in the year ended December 31, 2023. As of December 31, 2024, the Company had cash and cash equivalents of approximately $4.2 million, compared to approximately $7.4 million on December 31, 2023. This unaudited preliminary and partial financial information regarding revenues for the year ended December 31,...

BRAINTREE, Mass., Feb. 11, 2025 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT) today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules for the purchase and sale of 6,103,289 shares of the Company’s common stock at a purchase price of $2.13 per share of common stock. In addition, in a concurrent private placement, the Company issued unregistered short-term series I preferred investment options. The short-term series I preferred investment options to purchase up to 12,206,578 shares of common stock have an exercise price of $2.13 per share and will be exercisable for a period of two years beginning on the later of (i) the effective date of the increase of the Company’s authorized shares of common stock following stockholder approval and (ii) the effective...

TORONTO, Feb. 11, 2025 (GLOBE NEWSWIRE) — ThreeD Capital Inc. (“ThreeD” or the “Company”) (CSE:IDK / OTCQX:IDKFF) a Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, announces that at January 31, 2025, its unaudited net asset value per share (“NAV”) was $0.60.   This announcement is made based on ThreeD’s established practice of releasing NAV on a monthly basis as part of the Company’s ongoing response to shareholder interest in receiving periodic information. NAV is calculated based on unaudited month-end financial information. Use of Non-GAAP Financial Measures: This press release contains references to NAV or “net asset value per share” which is a non-GAAP financial measure. NAV is calculated as the value of total assets less the...